Novel Routes to C3–C4 and C4–C5 Cyclopropanated Pyranosides
H), 5.02–5.15 (m, 2 H), 7.17 (d, J = 8.0 Hz, 2 H), 7.23–7.38 (m, 20 derivatives (slower moving compound by TLC) was then treated
H), 7.45 (d, J = 8.0 Hz, 2 H) ppm. 13C NMR (100 MHz, CDCl3): with a suspension of 90% tBuOK (0.17 g, 1.6 mmol) in dry THF
δ = 21.6, 34.7, 55.1, 59.7, 64.5 (CH2), 66.5, 72.7 (CH2), 73.8 (CH2),
75.2, 86.6, 95.0, 127.0, 127.7, 128.2, 128.3, 128.4, 128.6, 128.7,
129.9, 135.2, 137.1, 143.7, 145.0 ppm. HRMS (ESI+): calcd. for
C41H42NO8S [M + H]+ 708.2631; found 708.2630.
(5 mL) at room temperature for 2 h under an atmosphere of N2.
The volatile matters were then evaporated under reduced pressure.
The residue obtained in each case was triturated with EtOAc
(30 mL). The organic layer was washed with a saturated aqueous
solution of NH4Cl (3ϫ30 mL) and separated. The organic layer
was dried with anhydrous Na2SO4 and filtered, and the filtrate was
evaporated under reduced pressure to get a residue. The crude resi-
due obtained in each case was then purified over silica gel (EtOAc/
petroleum ether, 1:4) and the pure product was combined with the
previously obtained desired cyclopropane derivative to afford 17
Methyl 2-O-Benzyl-3,4-dideoxy-3-C-bis(methoxycarbonyl)methyl-4-
(4-methylphenyl)sulfonyl-6-O-triphenylmethyl-α-D-glucopyranoside
(12): Following the procedure described for the preparation of 11,
H2C(CO2Me)2 (0.15 mL, ≈2.5 mmol) was treated with 1 (0.33 g,
0.5 mmol) to get compound 12 within 16 h (0.31 g, 77%). White
solid (eluent: EtOAc/petroleum ether, 1:4). M.p. 112–114 °C. [α]2D8
= +31.2 (c = 0.625, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 2.41
(s, 3 H), 3.15 (s, 3 H), 3.18–3.25 (m, 1 H), 3.42–3.46 (m, 1 H), 3.50
(s, 3 H), 3.58–3.60 (m, 1 H), 3.67 (s, 3 H), 3.75–3.84 (m, 1 H), 3.98–
4.02 (m, 1 H), 4.39–4.43 (m, 1 H), 4.46–4.48 (m, 2 H), 4.54–4.60
(m, 2 H), 7.21–7.37 (m, 17 H), 7.40–7.48 (m, 5 H), 7.56 (d, J =
8.0 Hz, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 21.6, 36.1,
49.5, 52.1, 52.3, 54.9, 61.6, 64.9 (CH2), 66.9, 72.8 (CH2), 74.7, 95.6,
126.9, 127.7, 127.8, 127.9, 128.2, 128.5, 129.0, 129.6, 134.9, 137.8,
143.9, 144.7, 168.8, 169.2 ppm. HRMS (ESI+): calcd. for
C45H47O10S [M + H]+ 779.9137; found 779.9136.
(0.185 g, 83%). White crystalline solid. M.p. 141–143 °C [α]2D8
=
+35.1 (c = 0.625, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.07–
1.10 (m, 1 H), 1.96–1.99 (m, 1 H), 2.48 (s, 3 H), 2.93 (s, 3 H), 3.20–
3.26 (m, 2 H), 3.74–3.76 (m, 1 H), 4.24 (s, 1 H), 4.44–4.50 (m, 2
H), 4.54–4.59 (m, 1 H), 5.14–5.17 (m, 1 H), 7.21–7.34 (m, 5 H),
7.42 (d, J = 8.0 Hz, 2 H), 7.83 (d, J = 8.0 Hz, 2 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 15.5 (CH2), 21.7, 32.3, 42.2, 51.5, 55.3,
72.9 (CH2), 76.1 (CH2), 77.2, 95.1, 128.1, 128.3, 128.4, 128.5, 129.8,
133.6, 136.7, 145.2 ppm. HRMS (ESI+): calcd. for C22H26NO7S
[M + H]+ 448.1430; found 448.1428.
Methyl 2-O-Benzyl-4,6-cyclo-3-C-bis(methoxycarbonyl)methyl-4-(4-
methylphenyl)sulfonyl-3,4,6-trideoxy-α-D-glucopyranoside (19): Fol-
Methyl 2-O-Benzyl-3,4-dideoxy-3,4-cyclo-C-methylene-4-(4-meth-
ylphenyl)sulfonyl-6-O-triphenylmethyl-α-
D-glucopyranoside
(15):
lowing the procedure described for the preparation of 17,
H2C(CO2Me)2 (0.15 mL, ≈2.5 mmol) was treated with 2 (0.24 g,
0.5 mmol) to get compound 19 within 8 h. Yield: 0.21 g, 81%.
Colourless jelly (eluent: EtOAc/petroleum ether, 1:4). [α]2D8 = +37.1
(c = 0.625, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.32–1.35
(m, 1 H), 1.86–1.89 (m, 1 H), 2.46 (s, 3 H), 3.02 (s, 3 H), 3.07 (s, 3
H), 3.46 (s, 3 H), 3.48–3.51 (m, 1 H), 3.77 (s, 3 H), 4.02–4.05 (m,
1 H), 4.22–4.33 (m, 3 H), 4.43–4.46 (m, 1 H), 4.58–4.62 (m, 2 H),
4.74–4.77 (m, 1 H), 7.19–7.29 (br. s, 5 H), 7.40 (d, J = 8.0 Hz, 2
H), 7.80 (d, J = 8.0 Hz, 2 H) ppm. 13C NMR (100 MHz, CDCl3):
δ = 21.7, 36.0, 37.6, 49.4, 52.4, 55.3, 61.4, 64.8, 71.1 (CH2), 72.9
(CH2), 74.4, 95.7, 128.0, 128.3, 128.5, 129.5, 130.0, 133.0, 137.4,
145.8, 168.8, 168.9 ppm. HRMS (ESI+): calcd. for C26H31O9S [M
+ H]+ 519.1689; found 519.1682.
Compound 11 (0.71 g, 1 mmol) was dissolved in tBuOH (30 mL)
at 60 °C. To the warm solution was added tBuOK (0.28 g,
2.5 mmol). The mixture was stirred under an atmosphere of N2 for
20 min while cooling to room temperature and then ethyl acetate
(75 mL) was added. This was immediately followed by an ice-cold
solution of KMnO4 (0.156 g, 1 mmol) in water (30 mL). The mix-
ture was stirred vigorously for 20 min, and then the mixture was
extracted with EtOAc (3ϫ10 mL). The combined organic layers
were dried with anhydrous Na2SO4 and filtered, and the filtrate
was concentrated under reduced pressure to get residue 13. The
crude residue was dissolved in ethanol (10 mL), cooled in an ice
bath and sodium borohydride (2.5 equiv/mmol) was added; the
solution was stirred for 16 h. Then the reaction mixture was poured
into ice-cold water, and the mixture was extracted with EtOAc
(3ϫ10 mL). The combined organic layers were dried with anhy-
drous Na2SO4 and filtered, and the filtrate was concentrated under
reduced pressure to get a residue. The residue was then mesylated
by using standard conditions, and the mesylate derivative was
treated with tBuOK (0.34 g, 3.0 mmol) and THF (3 mL) for 3 h at
room temperature to get a residue. The resulting residue was puri-
fied over silica gel (EtOAc/petroleum ether, 1:4) to afford 15
(0.43 g, 65%). Colourless jelly. [α]2D8 = +17.1 (c = 0.625, CHCl3).
1H NMR (400 MHz, [D6]DMSO): δ = 0.89–0.93 (m, 1 H), 1.53–
1.57 (m, 1 H), 1.71–1.76 (m, 1 H), 2.42 (s, 3 H), 2.84–2.88 (m, 1
H), 3.00 (s, 3 H), 3.35–3.39 (m, 2 H), 4.20 (d, J = 7.2 Hz, 1 H),
4.49–4.59 (m, 3 H), 7.24–7.38 (m, 22 H), 7.52 (d, J = 8.0 Hz, 2
H) ppm. 13C NMR (100 MHz, [D6]DMSO): δ = 11.8 (CH2), 18.8,
20.9, 21.5, 54.9, 64.5, 65.1 (CH2), 70.6 (CH2), 72.2, 86.4, 94.4,
127.5, 128.0, 128.2, 128.3, 128.6, 128.7, 128.9, 129.9, 135.3, 138.5,
144.1, 144.9 ppm. HRMS (ESI+): calcd. for C41H41O6S [M + H]+
661.2624; found 661.2621.
Methyl
3,4,6-trideoxy-α-
2-O-Benzyl-4,6-cyclo-3-C-bis(methoxycarbonyl)methyl-
-glucopyranoside (20): Compound 19 (0.2 g,
D
0.4 mmol) was desulfonylated at room temperature by using Na/
Hg (6%)[7b] in MeOH in 4 h to afford 20 (0.095 g, 67%). Colourless
jelly (eluent: EtOAc/petroleum ether, 1:4). [α]2D8 = +34.8 (c = 0.625,
CHCl3). 1H NMR (400 MHz, CDCl3): δ = 0.30–0.33 (m, 1 H),
0.55–0.58 (m, 1 H), 1.46–1.50 (m, 1 H), 3.13–3.15 (m, 1 H), 3.32–
3.39 (m, 2 H), 3.41 (s, 3 H), 3.58 (s, 3 H), 3.64 (d, J = 6.4 Hz, 1
H), 3.69 (s, 3 H), 4.39 (s, 1 H), 4.50 (s, 2 H), 7.28–7.36 (m, 5
H) ppm. 13C NMR (100 MHz, CDCl3): δ = 9.81 (CH2), 14.8, 33.1,
47.3, 52.2, 53.6, 55.5, 72.5 (CH2), 76.4, 95.8, 127.8, 128.1, 128.3,
137.8, 168.8, 169.1 ppm. HRMS (ESI+): calcd. for C19H25O7 [M +
H]+ 365.1600; found 365.1601.
CCDC-732518 (for 17) contains the supplementary crystallo-
graphic data for this paper. These data can be obtained free of
charge from The Cambridge Crystallographic Data Centre via
www.ccdc.cam.ac.uk/data_request/cif.
Supporting Information (see footnote on the first page of this arti-
Methyl 2-O-Benzyl-4,6-cyclo-3-C-nitromethyl-4-(4-methylphenyl)-
sulfonyl-3,4,6-trideoxy-α-D-glucopyranoside (17): Following the pro-
1
cle): H and 13C NMR spectra for new compounds.
cedure described for the addition of C-nucleophiles to 1, CH3NO2
(0.15 mL, ≈ 2.5 mmol) was treated with 2 (0.24 g, 0.5 mmol) to af-
ford a mixture of two compounds within 8 h. The compound mix-
ture was separated by column chromatography over silica gel and
the desired cyclopropane derivative was preserved. The mesylate
Acknowledgments
T.P. thanks the Department of Science and Technology (DST),
New Delhi for financial support. R.B. and D.D. thank the Council
Eur. J. Org. Chem. 2009, 5255–5260
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5259